» Articles » PMID: 28774877

How I Treat Pediatric Venous Thromboembolism

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2017 Aug 5
PMID 28774877
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of pediatric venous thromboembolism (VTE) has been increasing significantly over the past decade in part as a result of increased recognition of this serious disorder but more so because of the increased use of central venous catheters and other technological advancements involved in the care of ill children. Management of pediatric VTE is a complex undertaking, considering that the vast majority of children who develop this complication have serious underlying medical disorders. Although the incidence is rising, in comparison with adults, this remains a relatively rare disorder, and as such, large-scale clinical trials have not been completed, rendering management decisions to be based on extrapolation from adult data and the experience of the treating physician. Clearly, both are fraught with problems. Thus, day-to-day management remains more art than science until such time that the results from clinical trials (many of which are under way) become available. This edition of "How I Treat" describes the author's experience in managing 3 common scenarios that one may encounter in pediatric thrombosis and suggests a logical approach to such situations. Furthermore, the author provides 3 algorithms to help guide management decisions.

Citing Articles

Pulmonary thromboembolism due to Mycoplasma pneumoniae in children: a case report and literature review.

Cheng R, Wang Q, Jiang L, Liu L BMC Pediatr. 2024; 24(1):816.

PMID: 39696161 PMC: 11656901. DOI: 10.1186/s12887-024-05283-z.


Selective iliofemoral stent placement for complex pediatric cases: a decade of institutional experience.

Karim S, Gayou E, Gross J, Prajapati H, Kukreja K, Chau A Pediatr Radiol. 2024; 54(9):1540-1548.

PMID: 38987429 DOI: 10.1007/s00247-024-05985-7.


Thromboembolism in Children: Unveiling Risk-Factors.

Roy P, Bansal D Indian J Pediatr. 2024; 91(7):655-656.

PMID: 38733449 DOI: 10.1007/s12098-024-05155-5.


How I treat pediatric venous thromboembolism in the DOAC era.

Bhat R, Young G, Sharathkumar A Blood. 2023; 143(5):389-403.

PMID: 37390311 PMC: 10862368. DOI: 10.1182/blood.2022018966.


Paediatric otogenic sinus venous thrombosis: the role of .

Yosefof E, Hilly O, Sokolov M, Raveh E, Yacobovich J, Ulanovski D Acta Otorhinolaryngol Ital. 2022; 42(4):388-394.

PMID: 36254655 PMC: 9577686. DOI: 10.14639/0392-100X-N1835.


References
1.
Goldenberg N, Abshire T, Blatchford P, Fenton L, Halperin J, Hiatt W . Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings. J Thromb Haemost. 2015; 13(9):1597-605. PMC: 4561031. DOI: 10.1111/jth.13038. View

2.
Zenz W, Arlt F, Sodia S, Berghold A . Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years. Semin Thromb Hemost. 1997; 23(3):321-32. DOI: 10.1055/s-2007-996104. View

3.
Beitzke A, Zobel G, Zenz W, Gamillscheg A, Stein J . Catheter-directed thrombolysis with recombinant tissue plasminogen activator for acute pulmonary embolism after fontan operation. Pediatr Cardiol. 1996; 17(6):410-2. DOI: 10.1007/s002469900091. View

4.
Raffini L, Huang Y, Witmer C, Feudtner C . Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics. 2009; 124(4):1001-8. DOI: 10.1542/peds.2009-0768. View

5.
Halton J, Lehr T, Cronin L, Lobmeyer M, Haertter S, Belletrutti M . Safety, tolerability and clinical pharmacology of dabigatran etexilate in adolescents. An open-label phase IIa study. Thromb Haemost. 2016; 116(3):461-71. DOI: 10.1160/TH15-04-0275. View